Rare diseases
Investigational molecules
Locations
Back to Belgium237 clinical trials in Antwerp, Belgium across 5 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Study on Anifrolumab for Adults with Polymyositis or Dermatomyositis
BelgiumStudy of LY3537982, pembrolizumab, and a drug combination for patients with advanced non-small cell lung cancer and a KRAS G12C mutation
BelgiumA Study of Baricitinib to Delay Type 1 Diabetes in Children and Adults at Risk of Developing the Disease
BelgiumEfficacy and safety of the investigational mRNA influenza vaccine gskvx000000077430 (drug combination) in adults ≥ 65 years
BelgiumStudy of LY3484356 (imlunestrant) with Tamoxifen Citrate and Goserelin Acetate in Premenopausal Women with ER‑Positive, HER2‑Negative Early Breast Cancer
BelgiumStudy of pelabresib (DAK539) plus ruxolitinib versus placebo plus ruxolitinib in adult patients with myelofibrosis who are JAK‑inhibitor‑naive
BelgiumA Phase 3b Study of Guselkumab Compared with Risankizumab in Adults with Moderately to Severely Active Crohn’s Disease
BelgiumRabies Prophylaxis in Healthy Volunteers After Rabies Virus (Inactivated) Strain Flury LEP Vaccination
BelgiumPumitamig Versus Pembrolizumab in Patients With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%
BelgiumStudy of Tirabrutinib, Rituximab, and Temozolomide in Patients with Relapsed/Refractory Primary Central Nervous System Lymphoma
BelgiumLetrozole During IVF/ICSI for Women with Endometriosis
BelgiumA study to evaluate the safety and effectiveness of filgotinib in children and adolescents aged 8 to 17 years with polyarticular juvenile idiopathic arthritis
BelgiumThe busiest research cities in the country
What the registry says about research in the country
Clinical trials focusing on preventive vaccines and treatments for various infectious diseases, including studies on influenza, rabies, and yellow fever immunization strategies.
Research includes innovative vaccination techniques and immune response evaluation in different age groups.
Comprehensive studies on various cancer types, with particular focus on leukemia and breast cancer treatments.
Investigating novel drug combinations and personalized treatment approaches for better patient outcomes.
Studies examining antimicrobial resistance and treatment optimization in various bacterial infections.
Focus on developing effective antimicrobial strategies while minimizing resistance development.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
